Figure 2.

Changes in SF-36 domain scores grouped according to extent of pain relief in patients treated with pregabalin.

Notes: Only SF-36 domains that exhibited significant improvement in response to pregabalin treatment, compared to placebo, are shown. Reprinted from The Journal of Pain. Vinik A, Zlateva G, Cheung R, Murphy K, Emir B, Whalen E. Understanding the impact of pain response on changes in function, quality of life, and sleep interference in patients with painful diabetic peripheral neuropathy and post-herpetic neuralgia treated with pregabalin. 2010;11:S17. Copyright 2010 with permission from Elsevier.²⁰